 |
 |
|
 |
||
Print 
Download Reader 
|
|
|
|
||
Print Download Reader
 |
|
DAB Menu
|
|
List of Acceptable Complaints
|
NCD Name |
NCD Number |
Board Docket Number |
Intervention Deadline |
Resolution |
|---|---|---|---|---|
Ocular Photodynamic Therapy |
80.2.1 |
A-02-75 |
10/7/2004 |
Dismissed |
Pancreas Transplants |
35-82 |
A-04-89 |
1/1/2006 |
Dismissed* |
Infusion Pumps |
60-14 |
A-04-118 |
10/7/2004 |
Dismissed |
Durable Medical Equipment Reference List — (Air Cleaners) |
280.1 |
A-04-145 |
11/1/2005 |
Decision issued finding that record supports validity of the NCD. (DAB No. 1999) |
Carcinoembryonic Antigen |
190.26 |
A-07-106 |
11/30/2007 |
Dismissed** |
* The Board ruled that the record was not complete and adequate to support
the validity of the NCD. CMS agreed to reconsider the NCD. The NCD complaint was dismissed after CMS revised the NCD to address the concerns raised.
** The Board ruled that the beneficiary was not entitled to challenge the NCD for carcinoembryonic antigen (CEA) testing because CMS had determined that the NCD did not bar coverage for indications not specifically listed in the NCD as either covered or excluded from coverage. Rather, CMS determined that coverage of CEA testing for such indications required individual showings that testing was reasonable and necessary based on individual medical circumstances. A redacted copy of the Board’s dismissal ruling can be read by clicking the following link: CEA NCD DISMISSAL RULING (PDF).
Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
Last revised: May 9, 2008
|
